Browse the evidence

Obesity is associated with a shift in the hedonic set point where metabolic satiety signals (leptin, insulin) fail to suppress the brain's reward circuits, leading to increased incentive motivation ('wanting') for food.

In obesity, the brain's reward system becomes less responsive to 'stop' signals from hormones like leptin and insulin. This means food cues trigger a strong drive to eat ('wanting') even when you are full. Understanding this biological shift can help reduce self-blame and focus on strategies that manage environmental food cues.

Long-term calorie restriction (30% reduction) slows the age-related decline of serum dehydroepiandrosterone sulfate (DHEAS) in adult rhesus monkeys, serving as a biomarker for slowed aging.

In rhesus monkeys, restricting calories by 30% significantly slowed the natural age-related drop in DHEAS, a hormone linked to aging. This suggests that caloric restriction may preserve hormonal health and slow aging processes in primates, though direct human application requires further study.

The duration of uninterrupted sedentary bouts (prolonged sitting) is not significantly associated with cancer mortality risk after adjusting for MVPA and other covariates.

Don't stress too much about sitting for long uninterrupted periods if you are already reducing your total daily sitting time. The total volume of sitting is the primary driver of cancer mortality risk in this study, not necessarily how long you sit without moving.

Lower extremity (leg) fat mass has no significant correlation with insulin resistance, distinguishing it from trunk/visceral fat depots.

Losing fat from your legs may not improve your metabolic health or insulin sensitivity. Focus on reducing visceral (belly) fat, as leg fat levels do not significantly correlate with insulin resistance.

Brown adipose tissue (BAT) is present and metabolically active in adult humans, where it contributes to energy expenditure and thermogenesis, challenging the prior belief that it is nonexistent or nonfunctional in adults.

You likely have active brown fat, even as an adult. It helps burn calories and regulate temperature. While you can't simply 'switch it on' with a pill without side effects, understanding its existence means your body has a built-in mechanism for energy expenditure that can be influenced by factors like cold exposure and diet.

Bariatric surgery (specifically Roux-en-Y gastric bypass and sleeve gastrectomy) resets the body fat set point to a lower level, resulting in sustained weight loss and reduced hunger through physiological mechanisms rather than simple caloric restriction.

For individuals with severe obesity who have struggled to maintain weight loss through diet and exercise alone, bariatric surgery offers a physiological reset of hunger and satiety signals. This biological change supports long-term weight maintenance more effectively than willpower-based dietary restriction alone, though it requires lifelong nutritional monitoring.

Insulin resistance in NAFLD creates a paradoxical state where insulin fails to suppress hepatic glucose production (causing hyperglycemia) while simultaneously stimulating de novo lipogenesis (causing hepatic steatosis).

If you have fatty liver, your body's insulin signaling is broken in a specific way: your liver ignores insulin's command to stop making sugar, but it still obeys insulin's command to make fat. This means standard 'low insulin' strategies might not address the root cause if they don't improve the specific insulin signaling pathway (PI3K-AKT) in the liver. Focus on improving overall insulin sensitivity through lifestyle changes rather than just avoiding insulin-producing foods.

Gradual advancement of the sleep-wake schedule combined with moderate indoor light exposure (90-150 lux) fails to advance the circadian phase and significantly reduces the amplitude of the melatonin rhythm.

If you are trying to shift your sleep schedule (e.g., for shift work or jet lag), relying on normal indoor lighting (like office or home lights) will not reset your body clock and may actually weaken your melatonin rhythm. To successfully shift your circadian phase, you likely need exposure to much brighter light (e.g., >10,000 lux) timed specifically relative to your body's temperature nadir, or you must accept a period of reduced circadian amplitude.

Melatonin deficiency or dysfunction is associated with a wide range of diseases beyond sleep disorders, including dementia, mood disorders, cancer, diabetes type 2, and severe pain.

Low melatonin levels are a common feature in many chronic conditions, including diabetes, cancer, and dementia. While treating the underlying disease is primary, addressing melatonin deficiency may support overall health and sleep.

At moderate-to-high aerobic exercise intensities (65-90% VO2max), glycogenolysis is regulated by posttransformational factors (free Pi and AMP) rather than the transformation of glycogen phosphorylase, which remains in excess of flux requirements.

To burn more glycogen during cardio, you must increase your power output (intensity), not just hope your enzymes are 'activated.' At moderate intensities, your body uses post-transformational signals (like AMP and Pi levels) to fine-tune exactly how much glycogen to break down, keeping the enzyme ready but not necessarily running at max capacity.

Pyruvate dehydrogenase (PDH) transformation scales directly with exercise power output and closely matches the flux of carbohydrate oxidation into the mitochondria.

As you increase your cycling intensity from moderate to high (up to 90% VO2max), your body increasingly activates the PDH enzyme to process carbohydrates for energy. This activation scales with your effort, ensuring that the more you push, the more efficiently your mitochondria can use the pyruvate generated from glycogen.

Metformin (1,500 mg) acutely increases postprandial GLP-1 secretion in patients with type 2 diabetes, contributing approximately 75% to its glucose-lowering effect via direct AMPK-dependent activation of intestinal L cells.

For patients with type 2 diabetes, taking metformin (typically 1,500 mg) with a meal triggers the release of GLP-1, a gut hormone that helps lower blood sugar. This gut-mediated effect accounts for a large portion (approx. 75%) of metformin's immediate glucose-lowering benefit. This mechanism is direct, dependent on AMPK activation in gut cells, and preserved in obese patients and those with diabetes.

Male sex is associated with higher cardiorespiratory fitness (CRF) compared to female sex.

On average, men have higher cardiorespiratory fitness than women. This is a biological difference, not a measure of worth. Regardless of sex, improving your fitness through activity is crucial for health. Focus on your own progress rather than comparing yourself to the opposite sex.

Plasma levels of CRAMP, EF-1α, stathmin, and chitinase enzyme activity serve as biomarkers for human aging and diseases associated with telomere shortening, correlating with biological age and disease severity.

If you are concerned about biological aging or chronic diseases like cirrhosis or MDS, blood tests measuring CRAMP, EF-1α, stathmin, and chitinase activity can provide a more accurate assessment of your biological age and disease risk than chronological age or standard markers like IL-6. These biomarkers increase with age and disease severity, offering a tool for personalized therapy planning.

Age-related decline in α-Klotho expression in muscle progenitor cells drives mitochondrial dysfunction and impaired muscle regeneration.

Maintaining or boosting α-Klotho levels may support muscle repair as you age. While direct supplementation isn't a standard consumer product yet, understanding this pathway highlights the importance of factors that support mitochondrial health and hormonal balance in aging.

Supplementation with exogenous α-Klotho restores mitochondrial DNA integrity and bioenergetics in aged muscle progenitor cells, enhancing functional regeneration.

Exogenous α-Klotho supplementation shows promise in restoring muscle regeneration in aged models by fixing mitochondrial function. This suggests potential future therapies for age-related muscle loss.

Restoration of mitochondrial ultrastructure via SS-31 peptide treatment rescues the regenerative defects caused by α-Klotho deficiency.

Targeting mitochondrial health with peptides like SS-31 may help overcome regeneration deficits in individuals with low α-Klotho levels.

Dietary resistant starch (RS) improves insulin sensitivity and reduces plasma insulin levels independently of the gut microbiota, likely through modulation of bile acid profiles and reduction of adipose tissue macrophage infiltration.

If you are trying to improve insulin sensitivity, adding resistant starch (like cooled potatoes, green bananas, or specific supplements like Hi-Maize) to your diet can help, even if you haven't focused on probiotics or prebiotics for your gut bacteria. The study used a 10% replacement of starch with RS in a high-fat diet context. For humans, this translates to incorporating RS-rich foods into meals, particularly those high in refined carbs or fats, to potentially lower fasting insulin levels through direct metabolic pathways involving bile acids and reduced inflammation in fat tissue.

Parathyroid hormone (PTH) mediates the relationship between low Vitamin D and non-energy-expenditure aspects of frailty (slowness, weakness) in men.

For older men with low Vitamin D, high PTH levels might be the actual cause of muscle weakness and slowness. Doctors should check PTH levels, not just Vitamin D, to understand frailty risk.

Gut microbiota dysbiosis, characterized by decreased diversity and increased Proteobacteria, contributes to the pathogenesis of NAFLD by disrupting intestinal permeability and promoting hepatic inflammation via the gut-liver axis.

Focus on gut health as part of liver health. A diet high in fiber and low in processed additives may support a healthy microbiome, potentially reducing the risk of NAFLD progression. Probiotics and prebiotics are mentioned as potential therapeutic strategies.

Choline metabolism by gut bacteria into Trimethylamine (TMA) and subsequently Trimethylamine-N-oxide (TMAO) contributes to NAFLD by decreasing VLDL export and promoting insulin resistance.

Be cautious with high-dose choline supplements if you have NAFLD. Your gut bacteria may convert it to TMAO, which is linked to liver steatosis and insulin resistance.

Shifting caloric intake to the resting stage (daytime for mice) promotes obesity, while shifting it to the active stage (nighttime) protects against obesity, independent of total 24-hour caloric intake.

For humans, this suggests that eating more during your active/waking hours and less during your rest/sleep hours may support weight management, even if total calories remain constant. This aligns with the concept of time-restricted eating focused on the active phase.

Peripheral oxytocin (OXT) administration can activate hypothalamic oxytocin neurons and normalize feeding circadian rhythms to counteract obesity, offering a non-invasive therapeutic avenue.

This research suggests oxytocin plays a key role in metabolic health. While direct injection is not a current consumer solution, it highlights the importance of circadian eating patterns and may inform future non-invasive therapies.

Cyclical variation in heart rate (bradycardia during apnea, tachycardia upon arousal) combined with ECG waveform morphology changes (R and T wave amplitude modulation) can reliably detect obstructive sleep apnea (OSA).

For diagnosing sleep apnea, relying solely on oxygen saturation is insufficient due to physiological delays. A more reliable approach involves analyzing the cyclical heart rate changes (diving reflex) and ECG waveform morphology (R/T wave amplitude shifts) caused by respiratory effort.